American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.

By B. Hillner, J. Ingle, R. Chlebowski, J. Gralow, G. Yee, N. Janjan, J. Cauley, B. Blumenstein, K. Albain, A. Lipton and 1 more. Journal of Clinical Oncology, 2003

966 citations recorded by the source corpus.

Subfields: Oncology, Orthopedics and Sports Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/41a843ba0dc8b0e47a5fa63a7013e10f22bcf47e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. E. Stovall
2. S. Greenfield
3. A. F. Stewart
4. Qi Jiang
5. S. Jun
6. M. Hewitt
7. R. Dansey

In Orthopedics and Sports Medicine

1. Qi Jiang
2. S. Jun
3. R. Dansey

Citations in the corpus

• Pathologic fractures correlate with reduced survival in patients with malignant bone disease (2007, background): “Treatment guidelines from the American Society of Clinical Oncology recommend either intravenous pamidronate (Aredia, Novartis, Basel, Switzerland; 90 mg) or intravenous zoledronic acid (Zometa, Novartis; 4 mg) every 3 to 4 weeks for patients with evidence of bone destruction as a result of bone met”
• Hypercalcemia Associated with Cancer (2005, background): “Direct comparison of sustained infusion of human parathyroid hormone-related protein(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.”
• Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. (2010, background): “The American Society of Clinical Oncology recommends initiating treatment with intravenous bisphosphonates in breast cancer patients who have evidence of bone destruction on plain radiographs.(10) However, SREs still occur in a large proportion of patients despite intravenous JOURNAL OF CLINICAL ONC”
• From cancer patient to cancer survivor : lost in transition (2006, background): “Breast Cancer Reference/ Study Question Methods Mammography surveillance Method: Linkage of data from seven mammography following breast cancer registries (NCI’s Breast Cancer Surveillance (Geller et al., 2003) Consortium (BCSC)) to population-based cancer _________ and pathology registries.”